SE8704204D0 - Substituted alfa-aminoacids, their preparation and pharmaceutical compositions containing them - Google Patents
Substituted alfa-aminoacids, their preparation and pharmaceutical compositions containing themInfo
- Publication number
- SE8704204D0 SE8704204D0 SE8704204A SE8704204A SE8704204D0 SE 8704204 D0 SE8704204 D0 SE 8704204D0 SE 8704204 A SE8704204 A SE 8704204A SE 8704204 A SE8704204 A SE 8704204A SE 8704204 D0 SE8704204 D0 SE 8704204D0
- Authority
- SE
- Sweden
- Prior art keywords
- aminoacids
- preparation
- pharmaceutical compositions
- compositions containing
- alfa
- Prior art date
Links
- 235000001014 amino acid Nutrition 0.000 title 1
- 150000001413 amino acids Chemical class 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 2
- 208000019901 Anxiety disease Diseases 0.000 abstract 1
- 206010021143 Hypoxia Diseases 0.000 abstract 1
- 150000001371 alpha-amino acids Chemical class 0.000 abstract 1
- 235000008206 alpha-amino acids Nutrition 0.000 abstract 1
- 230000036506 anxiety Effects 0.000 abstract 1
- 230000002490 cerebral effect Effects 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 230000003412 degenerative effect Effects 0.000 abstract 1
- 208000035475 disorder Diseases 0.000 abstract 1
- 206010015037 epilepsy Diseases 0.000 abstract 1
- 230000001146 hypoxic effect Effects 0.000 abstract 1
- 208000020016 psychiatric disease Diseases 0.000 abstract 1
- 201000000980 schizophrenia Diseases 0.000 abstract 1
- 230000028327 secretion Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
- C07F9/3804—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)] not used, see subgroups
- C07F9/3882—Arylalkanephosphonic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, ***e
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
- C07F9/40—Esters thereof
- C07F9/4003—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
- C07F9/4056—Esters of arylalkanephosphonic acids
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Neurosurgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurology (AREA)
- Pharmacology & Pharmacy (AREA)
- Biomedical Technology (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Vascular Medicine (AREA)
- Anesthesiology (AREA)
- Cardiology (AREA)
- Hospice & Palliative Care (AREA)
- Urology & Nephrology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB868625941A GB8625941D0 (en) | 1986-10-30 | 1986-10-30 | Substituted alpha-amino acids |
Publications (3)
Publication Number | Publication Date |
---|---|
SE8704204D0 true SE8704204D0 (sv) | 1987-10-28 |
SE8704204L SE8704204L (sv) | 1988-05-01 |
SE466311B SE466311B (sv) | 1992-01-27 |
Family
ID=10606531
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE8704204A SE466311B (sv) | 1986-10-30 | 1987-10-28 | Substituerade alfa -aminosyror, deras framstaellning och farmaceutiska kompositioner innehaallande desamma |
Country Status (27)
Country | Link |
---|---|
US (1) | US5162311A (sv) |
JP (2) | JPH0641475B2 (sv) |
KR (1) | KR950004960B1 (sv) |
AT (1) | AT393384B (sv) |
AU (1) | AU614726B2 (sv) |
BE (1) | BE1002421A4 (sv) |
CA (1) | CA1310331C (sv) |
CH (1) | CH677794A5 (sv) |
CY (1) | CY1703A (sv) |
DE (1) | DE3736016C2 (sv) |
DK (1) | DK565987A (sv) |
ES (1) | ES2012521A6 (sv) |
FI (1) | FI87222C (sv) |
FR (1) | FR2606018B1 (sv) |
GB (2) | GB8625941D0 (sv) |
GR (1) | GR871659B (sv) |
HK (1) | HK110393A (sv) |
HU (1) | HU200465B (sv) |
IE (1) | IE59310B1 (sv) |
IL (1) | IL84302A (sv) |
IT (1) | IT1212033B (sv) |
LU (1) | LU87031A1 (sv) |
NL (1) | NL8702485A (sv) |
NZ (1) | NZ222333A (sv) |
PT (1) | PT86018B (sv) |
SE (1) | SE466311B (sv) |
ZA (1) | ZA878176B (sv) |
Families Citing this family (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5395827A (en) * | 1986-04-09 | 1995-03-07 | Guilford Pharmaceuticals Inc. | ω-[2-(phosphonoalkyl)phenyl]-2-aminoalkanoic acids as antagonists of excitatory amino acid receptors |
US4918064A (en) * | 1987-10-21 | 1990-04-17 | G. D. Searle & Co. | Phenyl glycines for use in reducing neurotoxic injury |
US5175153A (en) * | 1987-11-30 | 1992-12-29 | Warner-Lambert Company | Substituted alpha-amino acids having pharmaceutical activity |
FR2634763B1 (fr) * | 1988-08-01 | 1991-07-12 | Inst Nat Sante Rech Med | Amino-acides et peptides presentant un residu tyrosine modifiee, leur preparation et leur application comme medicaments |
US5177240A (en) * | 1988-10-21 | 1993-01-05 | G. D. Searle & Co. | O-phosphono(alkyl)-n-sulfonyl-phenyl-alanine derivatives useful as intermediates for preparation of phosphono-hydroisoquinolines |
US4997821A (en) * | 1988-10-21 | 1991-03-05 | Cordi Alexis A | Phosphono-hydroisoquinoline compounds useful in reducing neurotoxic injury |
US5100654A (en) * | 1989-04-07 | 1992-03-31 | Yale University | Phosphorylated derivatives of l-dopa and compositions and methods for increasing the melanin content in mammalian skin and hair |
DE3940410A1 (de) * | 1989-12-04 | 1991-06-06 | Schering Ag | Neue verwendung von nmda-rezeptor-antagonisten |
US5238958A (en) * | 1990-02-26 | 1993-08-24 | Warner-Lambert Company | Substituted α-amino acids having selected acidic moieties for use as excitatory amino acid antagonists in pharmaceuticals |
US5086072A (en) * | 1990-06-18 | 1992-02-04 | The United States Of America As Represented By The Department Of Health And Human Services | Treatment of mood disorders with functional antagonists of the glycine/nmda receptor complex |
US5200546A (en) * | 1991-09-30 | 1993-04-06 | The United States Of America As Represented By The Department Of Health And Human Services | Phosphonoalkyl phenylalanine compounds suitably protected for use in peptide synthesis |
US5264607A (en) * | 1991-09-30 | 1993-11-23 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Process of making benzylic α,α-diflurophosphonates from benzylic α-ketophosphorates |
US5475129A (en) * | 1991-09-30 | 1995-12-12 | The United States Of America As Represented By The Department Of Health And Human Services | Phosphonoalkyl phenylalanine compounds suitably protected for use in peptide synthesis |
GB9325360D0 (en) * | 1993-12-10 | 1994-02-16 | Univ Bristol | Organic compounds |
US5489717A (en) * | 1994-07-08 | 1996-02-06 | Warner-Lambert Company | Glutamate (NMDA) receptor antagonists |
GB9423019D0 (en) * | 1994-11-15 | 1995-01-04 | Sandoz Ltd | Improvements in or relating to organic compounds |
US5922697A (en) * | 1996-10-02 | 1999-07-13 | Warner-Lambert Company | Compounds, compositions and methods for inhibiting the binding of proteins containing an SH2 domain to cognate phosphorylated proteins |
US6133281A (en) * | 1996-10-24 | 2000-10-17 | Harbor-Ucla Research And Education Institute | NMDA receptor blockers in the therapy of urogenital disease |
ES2395268T3 (es) * | 1997-09-04 | 2013-02-11 | Demerx, Inc. | Noribogaína para el tratamiento del dolor y la drogadicción |
MY153569A (en) * | 1998-01-20 | 2015-02-27 | Mitsubishi Tanabe Pharma Corp | Inhibitors of ?4 mediated cell adhesion |
SE9804064D0 (sv) | 1998-11-25 | 1998-11-25 | A & Science Invest Ab | Medicinal product and method for treatment of conditions affecting neural stem cells or progenitor cells |
MY140707A (en) * | 2002-02-28 | 2010-01-15 | Mitsubishi Tanabe Pharma Corp | Process for preparing a phenylalanine derivative and intermediates thereof |
DE10328260A1 (de) * | 2003-06-23 | 2005-01-27 | Schmidt, K.-G., Dr. med. | Flupirtine-Präparat |
EP1754483A1 (en) * | 2005-08-18 | 2007-02-21 | Merck Sante | Use of thienopyridone derivatives as AMPK activators and pharmaceutical compositions containing them |
EP2580241B1 (en) | 2010-06-09 | 2020-11-04 | Queen Mary & Westfield College, University of London | Annexin 1 antibody |
GB201121564D0 (en) * | 2011-12-14 | 2012-01-25 | Queen Mary & Westfield College | Use of antibody |
GB201702091D0 (en) | 2017-02-08 | 2017-03-22 | Medannex Ltd | Specific binding molecules |
EP3427729A1 (en) | 2017-07-13 | 2019-01-16 | Paris Sciences et Lettres - Quartier Latin | Probenecid for use in treating epileptic diseases, disorders or conditions |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BE550634A (sv) * | 1955-08-30 | |||
NL287277A (sv) * | 1961-12-30 | |||
DE2459491A1 (de) * | 1974-12-17 | 1976-06-24 | Bayer Ag | Gegenueber isocyanaten reaktive phosphorhaltige flammschutzmittel |
US4657899A (en) * | 1986-04-09 | 1987-04-14 | Nova Pharmaceutical Corporation | Antagonists of specific excitatory amino acid neurotransmitter receptors |
US4761405A (en) * | 1987-03-04 | 1988-08-02 | Nova Pharmaceutical Corporation | Antagonists of specific excitatory amino acid neurotransmitter receptors having increased potency |
US4918064A (en) * | 1987-10-21 | 1990-04-17 | G. D. Searle & Co. | Phenyl glycines for use in reducing neurotoxic injury |
-
1986
- 1986-10-30 GB GB868625941A patent/GB8625941D0/en active Pending
-
1987
- 1987-10-15 GB GB8724186A patent/GB2198134B/en not_active Expired - Lifetime
- 1987-10-16 HU HU874665A patent/HU200465B/hu not_active IP Right Cessation
- 1987-10-16 NL NL8702485A patent/NL8702485A/nl active Search and Examination
- 1987-10-23 CH CH4169/87A patent/CH677794A5/de not_active IP Right Cessation
- 1987-10-23 DE DE3736016A patent/DE3736016C2/de not_active Expired - Fee Related
- 1987-10-26 BE BE8701221A patent/BE1002421A4/fr not_active IP Right Cessation
- 1987-10-26 FR FR878714891A patent/FR2606018B1/fr not_active Expired - Lifetime
- 1987-10-28 SE SE8704204A patent/SE466311B/sv not_active IP Right Cessation
- 1987-10-28 NZ NZ222333A patent/NZ222333A/xx unknown
- 1987-10-28 DK DK565987A patent/DK565987A/da not_active Application Discontinuation
- 1987-10-28 LU LU87031A patent/LU87031A1/fr unknown
- 1987-10-28 IT IT8748544A patent/IT1212033B/it active
- 1987-10-28 AU AU80404/87A patent/AU614726B2/en not_active Ceased
- 1987-10-28 PT PT86018A patent/PT86018B/pt not_active IP Right Cessation
- 1987-10-28 IL IL84302A patent/IL84302A/xx not_active IP Right Cessation
- 1987-10-29 JP JP62274594A patent/JPH0641475B2/ja not_active Expired - Lifetime
- 1987-10-29 KR KR1019870011983A patent/KR950004960B1/ko not_active IP Right Cessation
- 1987-10-29 FI FI874761A patent/FI87222C/sv not_active IP Right Cessation
- 1987-10-29 IE IE290887A patent/IE59310B1/en not_active IP Right Cessation
- 1987-10-29 CA CA000550571A patent/CA1310331C/en not_active Expired - Lifetime
- 1987-10-29 GR GR871659A patent/GR871659B/el unknown
- 1987-10-29 AT AT2851/87A patent/AT393384B/de not_active IP Right Cessation
- 1987-10-30 ES ES8703112A patent/ES2012521A6/es not_active Expired - Lifetime
- 1987-10-30 ZA ZA878176A patent/ZA878176B/xx unknown
-
1990
- 1990-08-02 JP JP2206678A patent/JPH03101685A/ja active Pending
-
1991
- 1991-08-19 US US07/747,177 patent/US5162311A/en not_active Expired - Fee Related
-
1993
- 1993-10-21 HK HK1103/93A patent/HK110393A/xx not_active IP Right Cessation
-
1994
- 1994-01-14 CY CY170394A patent/CY1703A/xx unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SE8704204D0 (sv) | Substituted alfa-aminoacids, their preparation and pharmaceutical compositions containing them | |
IL107884A0 (en) | Sulphonamides, their manufacture and pharmaceutical compositions containing them | |
IL107843A0 (en) | Aminomethylene substituted non-aromatic heterocycles | |
TW218869B (sv) | ||
AU8122791A (en) | Benzimidazoles | |
HU9202583D0 (en) | Hidantoine derivatives | |
HU9402933D0 (en) | Neurotensine-receptor-active 1-naphtyl-pyrazol-3-carboxamides process for producing them and pharmaceutical compositions containing them as active components | |
IL112074A0 (en) | Branched-amino-substituted thiazoles, their preparation and pharmaceutical compositions containing them | |
JPS6419066A (en) | Dihydropyridineamides | |
GR77719B (sv) | ||
GR3021303T3 (en) | Benzimidazoles, pharmaceutical compositions containing them and process for their preparation | |
ATE113591T1 (de) | 4-benzyl-5-phenyl-2,4-dihydro-3h-1,2,4-triazol- - one und ihre verwendung als antikonvulsiva. | |
GR3017358T3 (en) | 5-Aryl-3H-1,2,4-triazol-3-ones and their use as anticonvulsants. | |
ATE116851T1 (de) | 5-aryl-3h-1,2,4-triazol-3-one und ihre verwendung in der behandlung neurodegenerativer beschwerden. | |
DK259589D0 (da) | Joderede, ikke-ioniske trijodbenzenforbindelser og kontrastmiddel indeholdende dem | |
HK1000244A1 (en) | Use of naphthoxazines | |
ZA937179B (en) | Tetrahydorindazolone pharmaceutical compositions |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
NAL | Patent in force |
Ref document number: 8704204-0 Format of ref document f/p: F |
|
NUG | Patent has lapsed |
Ref document number: 8704204-0 Format of ref document f/p: F |